Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-10-15
DOI
https://doi.org/10.3389/fonc.2025.1667282
Citations
4
Primary Topic
Ocular Oncology and Treatments
Type
article
Field-Weighted Citation Impact
6.83
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis

Wen Sun, Yanlin Wang, Bing Wang
4 citations
Frontiers in Oncology
Ocular Oncology and Treatments
6.83
article

Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis

Wen Sun, Yanlin Wang, Bing Wang
article en
4 citations

Abstract

No abstract available for this paper.
Frontiers in OncologyVol. 15
Yantai Infectious Diseases Hospital (CN), Yantaishan Hospital (CN)
Openalex Percentile: Top 3%
Ocular Oncology and Treatments
6.83
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: a 2025 update systematic review and meta-analysis — Wen Sun, Yanlin Wang, et al. · Frontiers in Oncology (2025) | TGRS Research Map | TGRS